NZ622598A - Treating acute decompensated heart failure with relaxin - Google Patents
Treating acute decompensated heart failure with relaxinInfo
- Publication number
- NZ622598A NZ622598A NZ622598A NZ62259809A NZ622598A NZ 622598 A NZ622598 A NZ 622598A NZ 622598 A NZ622598 A NZ 622598A NZ 62259809 A NZ62259809 A NZ 62259809A NZ 622598 A NZ622598 A NZ 622598A
- Authority
- NZ
- New Zealand
- Prior art keywords
- relaxin
- heart failure
- treating acute
- decompensated heart
- acute decompensated
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Discloses the use of active H2 relaxin in the manufacture of a medicament for reducing congestion in a hypertensive or normotensive human subject with acute heart failure, wherein the N-terminal fragement brain natriuretic peptide (NT-BNP) levels are lower in subjects who were administered the medicament comprising relaxin than in subjects who were administered a placebo.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ701038A NZ701038A (en) | 2008-05-16 | 2009-05-15 | Treating acute decompensated heart failure with relaxin |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12788908P | 2008-05-16 | 2008-05-16 | |
US19054508P | 2008-08-28 | 2008-08-28 | |
US20124008P | 2008-12-08 | 2008-12-08 | |
US16433309P | 2009-03-27 | 2009-03-27 | |
NZ61281509 | 2009-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ622598A true NZ622598A (en) | 2014-12-24 |
Family
ID=52465011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ622598A NZ622598A (en) | 2008-05-16 | 2009-05-15 | Treating acute decompensated heart failure with relaxin |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ622598A (en) |
-
2009
- 2009-05-15 NZ NZ622598A patent/NZ622598A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL247351A0 (en) | Pharmaceutically active human h2 relaxin for use as a medicament for treating dyspnea associated with acute heart failure | |
MX343360B (en) | Peptide conjugates of glp-1 receptor agonists and gastrin and their use. | |
GEP20176629B (en) | Glucagon/glp-1 receptor co-agonists | |
NZ707292A (en) | Activin-actrii antagonists and uses for increasing red blood cell levels | |
MX2012002449A (en) | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency. | |
IL201479A (en) | Use of tapentadol for the manufacture of a medicament for the treatment of pain | |
EA201170149A1 (en) | NEW ANALOGUES INSULIN OF PROLONGED ACTIVITY | |
MX2010005331A (en) | Compositions and methods for treating purpura. | |
MX336145B (en) | Method of treating chronic heart failure. | |
MX2020008041A (en) | Method for delivering drug to muscle. | |
MX2013002244A (en) | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2. | |
MX2014005351A (en) | Glp-1 receptor agonist peptide gastrin conjugates. | |
MX2009007085A (en) | Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof. | |
NZ592612A (en) | Vasoactive intestinal peptide (VIP) Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-X for the treatment of kidney disorders | |
HK1143066A1 (en) | Ranolazine for elevated brain-type natriuretic peptide | |
NZ608266A (en) | Administration of lorcaserin to individuals with renal impairment | |
WO2011057027A3 (en) | Method for treating heart failure with stresscopin-like peptides | |
WO2010093993A3 (en) | Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance | |
NZ590469A (en) | Treatment of rheumatoid arthritis with human beta defensins (1-4) | |
MX2010008280A (en) | Composition for stimulating natural killer cell activity. | |
NZ622598A (en) | Treating acute decompensated heart failure with relaxin | |
EP1997503A3 (en) | Treatment of melanoma with alpha thymosin peptides | |
AU2016219717A1 (en) | Treating dyspnea associated with acute heart failure with relaxin | |
WO2012074559A3 (en) | Treatment of non-proliferative cystic disease | |
AU2013201629B2 (en) | Treating dyspnea associated with acute heart failure with relaxin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 MAY 2016 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20150330 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 MAY 2017 BY CPA GLOBAL Effective date: 20160405 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 MAY 2018 BY CPA GLOBAL Effective date: 20170418 |
|
LAPS | Patent lapsed |